CHAPEL HILL, N.C., Oct. 9 /PRNewswire/ -- Recent studies by Best Practices, LLC have found that on average, there are approximately 34 R&D FTE's per Quality FTE in Pharmaceutical companies. Many companies indicate that they need 10-15% more Quality employees to effectively use a Risk-Based Approach. Does your organization have the optimal number of quality personnel and structure for Quality Assurance in R&D? What tools are companies using to effectively implement and track a Risk-Based Approach to Quality Assurance? To answer these questions, Best Practices LLC has put together a collection of 4 key Quality documents, the Pharma Quality Assurance Toolkit, to aid R&D Quality Executives in optimizing and improving the quality function in their organization.
To download a complimentary copy of our Pharma Quality Assurance Toolkit Bundle: Best Practices, Benchmarks and Case Studies for Pharmaceutical Program Excellence click or paste the following link in your browser: http://www3.best-in-class.com/dr282.htm. To access the abstract for the full document, click or paste the following link: http://www3.best-in- class.com/de457.htm
The findings from this Toolkit are the result of research conducted with leading Fortune 500 companies, such as Abbott Laboratories; Wyeth; Novartis; Johnson & Johnson; Eli Lilly; Boehringer-Ingelheim; Amgen; Aventis; GlaxoSmithKline; Cardinal Health; Mayne; Medarex; Bristol-Myers Squibb.
To access additional findings on quality topics, consider a membership with the Best Practice Database, an online resource containing more than $35 million in proprietary research conducted on behalf of executives from Fortune 500 companies.
To sign up for a tour of the research documents available in the Best
Practices Database, please click here:
|SOURCE Best Practices, LLC|
Copyright©2007 PR Newswire.
All rights reserved